PowerPoint Presentation New IDSA/AASLD Guidelines for Hepatitis C John Scott, MD, MSc Associate Professor, UW SoM Asst Director, Liver Clinic, Harborview Medical Center Presentation…

A4001078 and A4001095 48-week results of once-daily maraviroc (MVC) 150 mg in combination with ritonavir-boosted atazanavir (ATV/r) compared to emtricitabine/tenofovir (FTC/TDF)…

HIV-1 Resistance - Implications For Clinicians Joseph J. Eron Jr., MD Professor of Medicine University of North Carolina Disclosures Types of Resistance Tests Genotype and…

HIV-1 Resistance - Implications For Clinicians Joseph J. Eron Jr., MD Professor of Medicine University of North Carolina Disclosures Types of Resistance Tests Genotype and…

Agenda Update on Darunavir: Perry Mohammed Update on Etravirine: Rekha Sinha Update on TMC278: Peter Williams Update on TMC207: Karel De Beule HCV pipeline: Daniel de Schryver…

AASLD 2010 HCV Feedback October 29 - November 2, 2010 Boston, Massachusetts Dr Allister J Grant Consultant Hepatologist Leicester Liver Unit Boceprevir, a potent inhibitor…

ART Initiation: PrEP and Treatment-naïve patients Case 4: 65-year-old Man Newly Diagnosed, Has Other Health Issues Paul E. Sax, MD Clinical Director, Division of Infectious…

AASLD 2010 HCV Feedback October 29 - November 2, 2010 Boston, Massachusetts Dr Allister J Grant Consultant Hepatologist Leicester Liver Unit Boceprevir, a potent inhibitor…

PowerPoint Presentation Highlights from CROI 18th Conference on Retroviruses and Opportunistic Infections Boston, MA February 28 to March 3, 2011 Iván Meléndez-Rivera,…

Dapagliflozin Improves Hyperglycemia and Beta-Cell Function Without Increasing Hypoglycemic Episodes in Patients With Type 2 Diabetes Mellitus Afshin Salsali MD, Arnaud Bastien…